Sexually Transmitted Infections

Medicine & Life Sciences

1. Belgium 100%
2. HIV 90%
3. Syphilis 82%
4. Sexually Transmitted Diseases 72%
5. Neisseria gonorrhoeae 69%
6. Sexual and Gender Minorities 68%
7. Pre-Exposure Prophylaxis 61%
8. Gonorrhea 60%
9. South Africa 58%
10. Macrolides 45%
11. Treponema pallidum 40%
12. Neisseria 37%
13. Fluoroquinolones 30%
14. Mycoplasma genitalium 28%
15. Chlamydia 27%
16. Azithromycin 24%
17. Infection 22%
18. Sexual Partners 22%
19. Sexual Behavior 22%
20. Population 21%
21. Ciprofloxacin 19%
22. Kenya 18%
23. Chrysosporium 18%
24. Mycoses 17%
25. Mouthwashes 16%
26. Risk-Taking 15%
27. Bacterial Vaginosis 15%
28. Onygenales 14%
29. Cephalosporins 14%
30. Blastomyces 14%
31. Epidemics 14%
32. Fungi 13%
33. HIV Infections 13%
34. Quinolones 13%
35. Systematic Reviews 12%
36. Heterosexuality 11%
37. Cohort Studies 11%
38. Human Herpesvirus 2 11%
39. Microbial Drug Resistance 10%
40. Horizontal Gene Transfer 10%
41. Linear Models 10%
42. Ecosystem 10%
43. Acquired Immunodeficiency Syndrome 10%
44. Chlamydia trachomatis 10%
45. Epidemiology 9%
46. Neisseria meningitidis 9%
47. Guidelines 9%
48. Ceftriaxone 9%
49. Incidence 9%
50. Cryptococcus neoformans 9%
51. Urease 8%
52. Anti-Bacterial Agents 8%
53. Chlorhexidine 8%
54. Globus Pallidus 8%
55. Ethiopia 8%
56. Uganda 8%
57. Proteome 8%
58. Mutation 8%
59. Blastomycosis 8%
60. Uncertainty 7%
61. Cross-Sectional Studies 7%
62. Whole Genome Sequencing 7%
63. Urine 7%
64. Reagins 7%
65. Ribosomal Proteins 7%
66. SARS Virus 7%
67. Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 6%
68. Genes 6%
69. Sexual Health 6%
70. Animals 6%
71. Mass Spectrometry 6%
72. Polymerase Chain Reaction 6%
73. Antimicrobial Stewardship 6%
74. Confidence Intervals 6%
75. Observational Studies 6%
76. Therapeutics 6%
77. Africa South of the Sahara 6%
78. Syndemic 6%
79. Monkeypox virus 6%
80. Southern Africa 6%
81. Streptococcus pneumoniae 5%
82. Lymphogranuloma Venereum 5%
83. Escherichia coli 5%
84. Oropharynx 5%
85. Biomarkers 5%
86. Primary Health Care 5%
87. Eastern Africa 5%
88. Neurosyphilis 5%
89. Fungal Spores 5%
90. Trichomonas vaginalis 5%
91. Greenland 5%
92. Male Circumcision 5%
93. Mycology 5%
94. Microbiota 5%
95. Feathers 5%
96. Skin 5%
97. Logistic Models 5%
98. Immune Reconstitution Inflammatory Syndrome 5%
99. Post-Exposure Prophylaxis 5%